JP2023541203A5 - - Google Patents
Info
- Publication number
- JP2023541203A5 JP2023541203A5 JP2023517268A JP2023517268A JP2023541203A5 JP 2023541203 A5 JP2023541203 A5 JP 2023541203A5 JP 2023517268 A JP2023517268 A JP 2023517268A JP 2023517268 A JP2023517268 A JP 2023517268A JP 2023541203 A5 JP2023541203 A5 JP 2023541203A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063079217P | 2020-09-16 | 2020-09-16 | |
| US63/079,217 | 2020-09-16 | ||
| PCT/US2021/050649 WO2022060973A1 (en) | 2020-09-16 | 2021-09-16 | Tyk2 inhibitors and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023541203A JP2023541203A (ja) | 2023-09-28 |
| JP2023541203A5 true JP2023541203A5 (https=) | 2024-09-17 |
| JPWO2022060973A5 JPWO2022060973A5 (https=) | 2024-09-17 |
| JP7824938B2 JP7824938B2 (ja) | 2026-03-05 |
Family
ID=78086111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517268A Active JP7824938B2 (ja) | 2020-09-16 | 2021-09-16 | Ｔｙｋ２阻害剤およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230357273A1 (https=) |
| EP (1) | EP4214215A1 (https=) |
| JP (1) | JP7824938B2 (https=) |
| KR (1) | KR20230069984A (https=) |
| CN (1) | CN117279922B (https=) |
| AU (1) | AU2021345181A1 (https=) |
| CA (1) | CA3192621A1 (https=) |
| IL (1) | IL301385A (https=) |
| WO (1) | WO2022060973A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024539280A (ja) | 2021-10-25 | 2024-10-28 | カイメラ セラピューティクス， インコーポレイテッド | Ｔｙｋ２分解剤およびそれらの使用 |
| JP2025509596A (ja) * | 2022-03-16 | 2025-04-11 | アルミス インコーポレイテッド | Ｔｙｋ２阻害剤およびその使用 |
| WO2023178235A1 (en) * | 2022-03-16 | 2023-09-21 | Alumis Inc. | Tyk2 inhibitors and uses thereof |
| WO2023208244A1 (zh) * | 2022-04-29 | 2023-11-02 | 南京明德新药研发有限公司 | 大环类化合物及其应用 |
| WO2024199479A1 (zh) | 2023-03-31 | 2024-10-03 | 北京普祺医药科技股份有限公司 | 一种大环化合物、药物组合物及其用途 |
| WO2024222807A1 (en) * | 2023-04-27 | 2024-10-31 | Hangzhou Highlightll Pharmaceutical Co., Ltd | Novel macrocyclic heteroaryl derivatives as kinase inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2864839T3 (es) * | 2015-07-02 | 2021-10-14 | Turning Point Therapeutics Inc | Macrociclos de diarilo quirales como moduladores de proteína quinasas |
| US10479793B2 (en) * | 2015-11-18 | 2019-11-19 | Bristol-Myers Squibb Company | Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses |
| ES2902995T3 (es) * | 2016-10-07 | 2022-03-30 | Bristol Myers Squibb Co | Compuestos de imidazopiridazina útiles como moduladores de respuestas a IL-12, IL-23 y/o IFN alfa |
| TWI808958B (zh) * | 2017-01-25 | 2023-07-21 | 美商特普醫葯公司 | 涉及二芳基巨環化合物之組合療法 |
| CN120865208A (zh) * | 2019-01-23 | 2025-10-31 | 武田药品工业株式会社 | Tyk2抑制剂和其用途 |
| US20220135567A1 (en) * | 2019-02-07 | 2022-05-05 | Ventyx Biosciences, Inc. | Tyk2 pseudokinase ligands |
| CA3132632A1 (en) * | 2019-03-11 | 2020-09-17 | Esker Therapeutics, Inc. | Tyk2 inhibitors and uses thereof |
| AU2020247990A1 (en) * | 2019-03-26 | 2021-11-11 | Ventyx Biosciences, Inc. | TYK2 pseudokinase ligands |
-
2021
- 2021-09-16 AU AU2021345181A patent/AU2021345181A1/en active Pending
- 2021-09-16 JP JP2023517268A patent/JP7824938B2/ja active Active
- 2021-09-16 IL IL301385A patent/IL301385A/en unknown
- 2021-09-16 WO PCT/US2021/050649 patent/WO2022060973A1/en not_active Ceased
- 2021-09-16 US US18/026,309 patent/US20230357273A1/en active Pending
- 2021-09-16 CA CA3192621A patent/CA3192621A1/en active Pending
- 2021-09-16 KR KR1020237012767A patent/KR20230069984A/ko active Pending
- 2021-09-16 EP EP21789976.4A patent/EP4214215A1/en active Pending
- 2021-09-16 CN CN202180076687.5A patent/CN117279922B/zh active Active